YCYi-Guang Chen

Yi-Guang Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yi-Guang Chen has a total of 115 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Age-independent immune subtypes in type 1 diabetes exhibit distinct post-onset progression rates and immunotherapeutic responses

    by Amina Bedrat, Nathan A. Truchan, Tarun Pant, Shuang Jia, Mark F. Roethle, Yi-Guang Chen, Chien-Wei Lin, Martin J. Hessner

    Aims/hypothesis The development of improved prevention and treatment strategies for type 1 diabetes requires a deeper understanding of its heterogeneity. Our aim was to measure immunological heterogeneity among individuals with new-onset type 1 diabetes using plasma-induced transcription, bioinformatics tools and targeted follow-up analyses. Methods We analysed pre-intervention samples from 560 participants across six immunotherapy trials, using a plasma-induced transcriptional bioassay and a standardised reporter cell population. Results Transcriptomic profiling at baseline identified 2854 transcripts with high variation in at least five trials. Unsupervised clustering divided the participants into two subgroups that did not differ in mean age and whose classifications remained stable in post-baseline longitudinal samples, suggesting that subgroup assignments were not driven by transient relapsing and remitting immune activity (p=1.4 × 10−14). Phenotypic analyses and an independent new-onset type 1 diabetes cohort found subgroup 1 enriched for participants with neutral or low-risk HLA haplotypes and the youngest participants possessing the most rapid rate of C-peptide decline (p+CXCR3+CCR6− Th1 T cells (pp+CD45RO+CD62L+ central memory T cells (p=8.1 × 10−5) and retention of regulatory T cells (p=0.02). Conclusions/interpretation These findings support the existence of immunologically distinct type 1 diabetes subgroups and the possibility of future targeted therapeutic interventions. Data availability All microarray gene expression data files have been deposited at The National Center for Biotechnology Information Gene Expression Omnibus (accession no. GSE302205). Graphical Abstract

  • Open Access

    Both soluble and cell surface CD137 expressed by Foxp3+ CD4 T cells restrain autoimmune diabetes.

    by Rabia Nabi, Chien-Wei Lin, Yu Wang, Ashley E Ciecko, Bardees M Foda, Yushu Wang, Amber Drewek, Scott M Lieberman, William M Ridgway, Yi-Guang Chen

    CD137 is expressed in a subset of Foxp3+ regulatory CD4 T cells (Tregs), but its immunoregulatory role is not fully defined. Due to alternative splicing that removes the transmembrane domain-encoding exon, CD137 exists in both membrane and soluble forms. We investigated the function of CD137 in Foxp3+ Tregs using the NOD mouse model of type 1 diabetes (T1D). Foxp3+ Treg-specific deletion of CD137 reduced circulating soluble CD137 and accelerated T1D development, driven by heightened clonal expansion and differentiation of effector T cells in pancreatic islets. CD137 deficiency in Foxp3+ Tregs reduced their frequency in islets and impaired their differentiation toward a suppressive phenotype. Restoring soluble CD137 in Foxp3+ Tregs lacking its membrane form reduced islet T cell activation and mitigated T1D acceleration without altering the accumulation of suppressive Foxp3+ Tregs. Our results indicate that both soluble and membrane forms of CD137 expressed by Foxp3+ Tregs are critical for immunoregulation, and they independently restrain T1D development.

  • Open Access

    An interleukin-27-centered cytokine circuit regulates macrophage and T cell interactions in autoimmune diabetes

    by Ashley E. Ciecko, Rabia Nabi, Amber Drewek, David M. Schauder, Pavel N. Zakharov, Xiaoxiao Wan, Scott M. Lieberman, Weiguo Cui, Martin J. Hessner, Chien-Wei Lin, et al.


  • Open Access

    DropDAE: Denosing Autoencoder with Contrastive Learning for Addressing Dropout Events in scRNA-seq Data

    by Wanlin Juan, Kwang Woo Ahn, Yi-Guang Chen, Chien-Wei Lin

    Single-cell RNA sequencing (scRNA-seq) has revolutionized molecular biology and genomics by enabling the profiling of individual cell types, providing insights into cellular heterogeneity. Deep learning methods have become popular in single cell analysis for tasks such as dimension reduction, cell clustering, and data imputation. In this work, we introduce DropDAE, a denoising autoencoder (DAE) model enhanced with contrastive learning, to specifically address the dropout events in scRNA-seq data, where certain genes show very low or even zero expression levels due to technical limitations. DropDAE uses the architecture of a denoising autoencoder to recover the underlying data patterns while leveraging contrastive learning to enhance group separation. Our extensive evaluations across multiple simulation settings based on synthetic data and a real-world dataset demonstrate that DropDAE not only reconstructs data effectively but also further improves clustering performance, outperforming existing methods in terms of accuracy and robustness.

  • Open Access

    CCI: A Consensus Clustering-Based Imputation Method for Addressing Dropout Events in scRNA-Seq Data

    by Wanlin Juan, Kwang Woo Ahn, Yi-Guang Chen, Chien-Wei Lin

    Single-cell RNA sequencing (scRNA-seq) is a cutting-edge technique in molecular biology and genomics, revealing the cellular heterogeneity. However, scRNA-seq data often suffer from dropout events, meaning that certain genes exhibit very low or even zero expression levels due to technical limitations. Existing imputation methods for dropout events lack comprehensive evaluations in downstream analyses and do not demonstrate robustness across various scenarios. In response to this challenge, we propose a consensus clustering-based imputation (CCI) method. CCI performs clustering on each subset of data sampling across genes and summarizes clustering outcomes to define cellular similarities. CCI leverages the information from similar cells and employs the similarities to impute gene expression levels. Our comprehensive evaluations demonstrate that CCI not only reconstructs the original data pattern, but also improves the performance of downstream analyses. CCI outperforms existing methods for data imputation under different scenarios, exhibiting accuracy, robustness, and generalization.


  • Open Access

    IL-27 promotes pathogenic T cells in a mouse model of Sjögren's disease

    by Ivy L. Debreceni, Jennifer Y. Barr, Ellen M. Upton, Yi-Guang Chen, Scott M. Lieberman


  • Open Access

    Monocytes in type 1 diabetes families exhibit high cytolytic activity and subset abundances that correlate with clinical progression

    by Tarun Pant, Chien-Wei Lin, Amina Bedrat, Shuang Jia, Mark F. Roethle, Nathan A. Truchan, Ashley E. Ciecko, Yi-Guang Chen, Martin J. Hessner

    Monocytes are immune regulators implicated in the pathogenesis of type 1 diabetes (T1D), an autoimmune disease that targets insulin-producing pancreatic β cells. We determined that monocytes of recent onset (RO) T1D patients and their healthy siblings express proinflammatory/cytolytic transcriptomes and hypersecrete cytokines in response to lipopolysaccharide exposure compared to unrelated healthy controls (uHCs). Flow cytometry measured elevated circulating abundances of intermediate monocytes and >2-fold more CD14 + CD16 + HLADR + KLRD1 + PRF1 + NK-like monocytes among patients with ROT1D compared to uHC. The intermediate to nonclassical monocyte ratio among ROT1D patients correlated with the decline in functional β cell mass during the first 24 months after onset. Among sibling nonprogressors, temporal decreases were measured in the intermediate to nonclassical monocyte ratio and NK-like monocyte abundances; these changes coincided with increases in activated regulatory T cells. In contrast, these monocyte populations exhibited stability among T1D progressors. This study associates heightened monocyte proinflammatory/cytolytic activity with T1D susceptibility and progression and offers insight to the age-dependent decline in T1D susceptibility.


  • Open Access

    CXCL16-dependent scavenging of oxidized lipids by islet macrophages promotes differentiation of pathogenic CD8+ T cells in diabetic autoimmunity

    by Neetu Srivastava, Hao Hu, Orion J. Peterson, Anthony N. Vomund, Marta Stremska, Mohammad Zaman, Shilpi Giri, Tiandao Li, Cheryl F. Lichti, Pavel N. Zakharov, et al.


  • Open Access

    IL-13 promotes functional recovery after myocardial infarction via direct signaling to macrophages

    by Santiago Alvarez-Argote, Samantha J. Paddock, Michael A. Flinn, Caelan W. Moreno, Makenna C. Knas, Victor A. Almeida, Sydney L. Buday, Amirala Bakhshian Nik, Michaela Patterson, Yi-Guang Chen, et al.

    There is great interest in identifying signaling pathways that promote cardiac repair after myocardial infarction (MI). Prior studies suggest a beneficial role for IL-13 signaling in neonatal heart regeneration; however, the cell types mediating cardiac regeneration and the extent of IL-13 signaling in the adult heart after injury are unknown. We identified an abundant source of IL-13 and the related cytokine, IL-4, in neonatal cardiac type 2 innate lymphoid cells, but this phenomenon declined precipitously in adult hearts. Moreover, IL-13 receptor deletion in macrophages impaired cardiac function and resulted in larger scars early after neonatal MI. By using a combination of recombinant IL-13 administration and cell-specific IL-13 receptor genetic deletion models, we found that IL-13 signaling specifically to macrophages mediated cardiac functional recovery after MI in adult mice. Single transcriptomics revealed a subpopulation of cardiac macrophages in response to IL-13 administration. These IL-13–induced macrophages were highly efferocytotic and were identified by high IL-1R2 expression. Collectively, we elucidated a strongly proreparative role for IL-13 signaling directly to macrophages following cardiac injury. While this pathway is active in proregenerative neonatal stages, reactivation of macrophage IL-13 signaling is required to promote cardiac functional recovery in adults.


  • Heterogeneity of Islet-Infiltrating IL-21+ CD4 T Cells in a Mouse Model of Type 1 Diabetes

    by Ashley E Ciecko, Yu Wang, Stephanie Harleston, Amber Drewek, David V. Serreze, Aron M. Geurts, Chien-Wei Lin, Yi-Guang Chen

    IL-21 is essential for type 1 diabetes (T1D) development in the NOD mouse model. IL-21–expressing CD4 T cells are present in pancreatic islets where they contribute to T1D progression. However, little is known about their phenotype and differentiation states. To fill this gap, we generated, to our knowledge, a novel IL-21 reporter NOD strain to further characterize IL-21+ CD4 T cells in T1D. IL-21+ CD4 T cells accumulate in pancreatic islets and recognize β cell Ags. Single-cell RNA sequencing revealed that CD4 T effector cells in islets actively express IL-21 and they are highly diabetogenic despite expressing multiple inhibitory molecules, including PD-1 and LAG3. Islet IL-21+ CD4 T cells segregate into four phenotypically and transcriptionally distinct differentiation states, that is, less differentiated early effectors, T follicular helper (Tfh)–like cells, and two Th1 subsets. Trajectory analysis predicts that early effectors differentiate into both Tfh-like and terminal Th1 cells. We further demonstrated that intrinsic IL-27 signaling controls the differentiation of islet IL-21+ CD4 T cells, contributing to their helper function. Collectively, our study reveals the heterogeneity of islet-infiltrating IL-21+ CD4 T cells and indicates that both Tfh-like and Th1 subsets produce IL-21 throughout their differentiation process, highlighting the important sources of IL-21 in T1D pathogenesis.